Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 228
interventional 191
Observational 35
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 125
Drug|placebo 46
Combination Product 4
Behavioral|Drug 2
Biological 2
Dietary Supplement 2
Drug|Other|placebo 2
Drug|Procedure 2
Procedure 2
Device|Drug 1
Dietary Supplement|Drug|placebo 1
Drug|Other 1
placebo|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 115
NA 16
Turkey 8
United Kingdom 6
United States|Canada 5
Denmark 4
Italy 4
China 3
Australia 2
Brazil 2
France 2
Germany 2
India 2
Spain 2
United States|Germany 2
Austria 1
Belarus 1
Brazil|Denmark|Italy|Mexico|Russian Federation|South Africa 1
Canada 1
Italy|United States|Spain|United Kingdom 1
Korea, Republic of 1
Netherlands 1
Norway 1
Slovakia 1
Slovenia 1
Switzerland 1
Thailand 1
United States|Argentina|Canada|Germany|Italy|Korea, Republic of|Puerto Rico|Spain|United Kingdom 1
United States|Australia|France|Germany|Sweden|United Kingdom 1
United States|Chile 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 117
2 18
3 7
4 2
5 1
6 1
7 3
8 3
9 2
11 2
12 1
13 1
14 2
15 1
16 2
17 1
18 5
19 2
20 1
21 1
22 1
23 1
27 2
28 1
30 3
31 1
35 1
36 1
37 1
45 2
63 1
70 1
85 1
388 1

Phase

Phase Study_Count
Phase 2 52
Phase 3 47
Phase 4 39
Phase 1 25
N/A 21
Phase 1/Phase 2 4
Phase 2/Phase 3 3

Number of Arms

Number_of_Arms Count_of_Studies
1 50
2 69
3 23
4 14
5 2
6 5
10 1
NA 27

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 10.0000 6.000 8.0 3.00 31.00000 6.0000 4.0000
1st Qu. 30.0000 19.750 12.5 22.00 43.50000 77.0000 40.0000
Median 50.0000 34.000 14.5 46.00 56.00000 144.0000 100.0000
Mean 122.0952 89.875 19.0 67.70 58.33333 166.6383 267.7692
3rd Qu. 158.0000 65.000 21.0 81.75 72.00000 188.0000 147.0000
Max. 800.0000 496.000 39.0 322.00 88.00000 715.0000 6000.0000

Trial Group Type

group_type Group_Count
Experimental 205
Active Comparator 70
Placebo Comparator 55
NA 27
Other 22
No Intervention 11

Intervention Model

intervention_model Study_Count
Parallel Assignment 105
Single Group Assignment 60
Crossover Assignment 22
Factorial Assignment 2
NA 2

Primary Purpose

primary_purpose Study_Count
Treatment 152
Other 10
Basic Science 8
Diagnostic 6
NA 5
Prevention 3
Screening 3
Supportive Care 3
Health Services Research 1

Observational Studies

Studies by Country

Country Study_Count
United States 13
Germany 4
NA 3
Denmark 2
Italy 2
Switzerland 2
Turkey 2
Australia 1
Canada|Croatia|Germany|Kuwait|Romania|Russian Federation|Saudi Arabia|Slovenia|United Arab Emirates 1
France 1
Germany|Italy|Netherlands|Spain|Sweden|United Kingdom 1
Jordan|Australia|Austria|Bulgaria|Colombia|Czech Republic|Estonia|Germany|Hong Kong|Indonesia|Italy|Kazakhstan|Korea, Republic of|Latvia|Lebanon|Lithuania|Macedonia, The Former Yugoslav Republic of|Malaysia|Malta|Mexico|Moldova, Republic of|Philippines|Romania|Russian Federation|Saudi Arabia|Singapore|Slovenia|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
Netherlands 1
Russian Federation 1

Sites per Study

Site_count Study_Count
1 28
2 3
25 1
33 1
64 1
331 1

Enrollment Metrics

Measure Observational
Min 20.000
1st Qu 62.500
Median 178.500
Mean 1288.794
3rd Qu 521.750
Max 27778.000

Observation Model

observational_model Study_Count
Cohort 14
NA 7
Case-Only 5
Case Control 5
Case-Control 3
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 19
Cross-Sectional 10
NA 5
Retrospective 1

Registries

Studies by Country

Country Study_Count
Turkey 1
United States|Australia 1

Sites per Study

Site_count Study_Count
1 1
2 1

Enrollment Metrics

Measure Registries
Min 16
1st Qu 5012
Median 10008
Mean 10008
3rd Qu 15004
Max 20000

Registry Model

observational_model Study_Count
Case-Only 2

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
100 Years 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03282682 Strength Training as a Supplemental Therapy of Androgen Deficiency of the Aging Male https://ClinicalTrials.gov/show/NCT03282682 Completed Comenius University 2019-05-30
NCT03242408 Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021) https://ClinicalTrials.gov/show/NCT03242408 Completed Lipocine Inc. 2017-05-31
NCT03203681 Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters https://ClinicalTrials.gov/show/NCT03203681 Completed University of Miami 2020-06-01
NCT03126656 Effects of Testosterone on Myocardial Repolarization https://ClinicalTrials.gov/show/NCT03126656 Completed University of Roma La Sapienza 2017-04-30
NCT03091348 Subcutaneous vs. Intramuscular Testosterone https://ClinicalTrials.gov/show/NCT03091348 Completed Men’s Health Boston 2017-11-21
NCT03057899 Efficacy of Fenugreek Seed and Lespedeza Cuneata in TDS https://ClinicalTrials.gov/show/NCT03057899 Completed Pusan National University Hospital 2015-11-30
NCT02966652 Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism https://ClinicalTrials.gov/show/NCT02966652 Completed Diurnal Limited 2018-10-04
NCT02959853 Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot) https://ClinicalTrials.gov/show/NCT02959853 Completed Baylor College of Medicine 2018-11-20
NCT02956447 Administration of Kisspeptin in Patients With Hyperprolactinemia https://ClinicalTrials.gov/show/NCT02956447 Recruiting Massachusetts General Hospital 2022-03-31
NCT02953834 Kisspeptin Influence on Glucose Homeostasis https://ClinicalTrials.gov/show/NCT02953834 Recruiting Massachusetts General Hospital 2022-12-31
NCT02937740 Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natestoâ„¢ https://ClinicalTrials.gov/show/NCT02937740 Completed Acerus Pharmaceuticals Corporation 2017-10-31
NCT02921386 The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate https://ClinicalTrials.gov/show/NCT02921386 Completed Clarus Therapeutics, Inc. 2017-01-21
NCT02908074 A 6 Month Safety Extension Study of MBGS205 https://ClinicalTrials.gov/show/NCT02908074 Completed Mereo BioPharma 2018-09-08
NCT02847806 Effects of Replacement Therapy With Sexual Steroid Hormones on the Insulin Sensitivity of Hypogonadal Man https://ClinicalTrials.gov/show/NCT02847806 Completed University Hospital, Caen 2015-12-31
NCT02777242 Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism https://ClinicalTrials.gov/show/NCT02777242 Completed Antares Pharma Inc. 2016-08-31
NCT02758431 Cardiovascular Outcomes of Low Testosterone https://ClinicalTrials.gov/show/NCT02758431 Recruiting University of Colorado, Denver 2021-01-31
NCT02748005 Evaluation of Furosap in Human Volunteers https://ClinicalTrials.gov/show/NCT02748005 Completed Chemical Resources 2015-07-31
NCT02733133 Product Transference Study of Testagen™ TDS®-Testosterone https://ClinicalTrials.gov/show/NCT02733133 Enrolling by invitation Transdermal Delivery Solutions Corp 2020-10-31
NCT02730169 Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism https://ClinicalTrials.gov/show/NCT02730169 Completed Mereo BioPharma 2018-02-15
NCT02722278 A Study of Oral Testosterone Undecanoate (TU) in Hypogonadal Men https://ClinicalTrials.gov/show/NCT02722278 Completed Clarus Therapeutics, Inc. 2016-11-30
NCT02702882 The Efficacy Study of FUROSAP: A Testosterone Booster Supplement In Humans. https://ClinicalTrials.gov/show/NCT02702882 Completed Chemical Resources 2017-03-31
NCT02697188 Pilot Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men https://ClinicalTrials.gov/show/NCT02697188 Completed Clarus Therapeutics, Inc. 2008-04-30
NCT02672592 Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome https://ClinicalTrials.gov/show/NCT02672592 Completed University Hospital, Basel, Switzerland 2017-06-30
NCT02670343 Phlebotomy Study of Testosterone Undecanoate https://ClinicalTrials.gov/show/NCT02670343 Completed Clarus Therapeutics, Inc. 2016-03-31
NCT02653092 Reprometabolic Syndrome Mediates Subfertility in Obesity https://ClinicalTrials.gov/show/NCT02653092 Recruiting University of Colorado, Denver 2020-02-29
NCT02651688 A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene https://ClinicalTrials.gov/show/NCT02651688 Completed Repros Therapeutics Inc. 2017-05-02
NCT02514629 Testosterone, Metformin, or Both, for Hypogonadism in Obese Males https://ClinicalTrials.gov/show/NCT02514629 Completed Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 2016-07-12
NCT02504541 Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism https://ClinicalTrials.gov/show/NCT02504541 Completed Antares Pharma Inc. 2016-06-30
NCT02380755 Clomiphene Citrate for the Treatment of Obesity Related Male Hypogonadism https://ClinicalTrials.gov/show/NCT02380755 Completed University of Sao Paulo 2017-01-31
NCT02367105 Lifestyle Intervention and Testosterone Replacement in Obese Seniors https://ClinicalTrials.gov/show/NCT02367105 Completed VA Office of Research and Development 2019-07-31
NCT02366975 TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST https://ClinicalTrials.gov/show/NCT02366975 Completed University of Florence 2017-01-31
NCT02274181 An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration https://ClinicalTrials.gov/show/NCT02274181 Completed Repros Therapeutics Inc. 2015-01-31
NCT02248701 Testosterone Plus Finasteride Treatment After Spinal Cord Injury https://ClinicalTrials.gov/show/NCT02248701 Recruiting VA Office of Research and Development 2021-05-31
NCT02233751 Pharmacokinetic Study of Subcutaneous Testosterone Enanthate https://ClinicalTrials.gov/show/NCT02233751 Completed Antares Pharma Inc. 2014-10-31
NCT02222558 Oral Testosterone for the Treatment of Hypogonadism in Males https://ClinicalTrials.gov/show/NCT02222558 Completed TesoRx Pharma, LLC 2015-04-30
NCT02171390 Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy https://ClinicalTrials.gov/show/NCT02171390 Completed Gulhane School of Medicine 2012-06-30
NCT02159469 Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism https://ClinicalTrials.gov/show/NCT02159469 Completed Antares Pharma Inc. 2015-02-28
NCT02154477 Effect of Intranasal Insulin on LH Concentrations in Man https://ClinicalTrials.gov/show/NCT02154477 Completed Texas Tech University Health Sciences Center 2017-12-31
NCT02149264 A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males https://ClinicalTrials.gov/show/NCT02149264 Completed Ferring Pharmaceuticals 2015-05-31
NCT02137265 Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism https://ClinicalTrials.gov/show/NCT02137265 Recruiting University of Illinois at Chicago 2019-10-31
NCT02111473 The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism https://ClinicalTrials.gov/show/NCT02111473 Completed Gulhane School of Medicine 2012-05-31
NCT02111434 Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment https://ClinicalTrials.gov/show/NCT02111434 Completed Gulhane School of Medicine 2014-04-30
NCT02110368 Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions https://ClinicalTrials.gov/show/NCT02110368 Completed Amneal Pharmaceuticals, LLC 2014-03-31
NCT02102646 MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism https://ClinicalTrials.gov/show/NCT02102646 Completed Herlev Hospital 2015-10-31
NCT02081300 Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism https://ClinicalTrials.gov/show/NCT02081300 Completed Lipocine Inc. 2015-05-31
NCT01270841 Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism https://ClinicalTrials.gov/show/NCT01270841 Completed Repros Therapeutics Inc. 2011-12-31
NCT01993225 A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% https://ClinicalTrials.gov/show/NCT01993225 Completed Repros Therapeutics Inc. 2014-08-31
NCT01993212 A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% https://ClinicalTrials.gov/show/NCT01993212 Completed Repros Therapeutics Inc. 2014-09-30
NCT01976728 LutrePulse Hypogonadotropic Hypogonadism https://ClinicalTrials.gov/show/NCT01976728 Completed Ferring Pharmaceuticals 2018-02-23
NCT01952782 Neuropeptides in Human Reproduction https://ClinicalTrials.gov/show/NCT01952782 Recruiting Massachusetts General Hospital 2022-08-31
NCT01923870 Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function https://ClinicalTrials.gov/show/NCT01923870 Completed Repros Therapeutics Inc. 2014-01-31
NCT01923857 Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function https://ClinicalTrials.gov/show/NCT01923857 Completed Repros Therapeutics Inc. 2014-08-31
NCT01919294 Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) https://ClinicalTrials.gov/show/NCT01919294 Completed Sheffield Teaching Hospitals NHS Foundation Trust 2017-01-30
NCT01894308 A Dose Ranging Study to Examine Testagen® TDS-Testosterone 5% https://ClinicalTrials.gov/show/NCT01894308 Enrolling by invitation Transdermal Delivery Solutions Corp 2020-11-30
NCT01893281 The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel https://ClinicalTrials.gov/show/NCT01893281 Completed Eli Lilly and Company 2014-01-31
NCT01887418 Pharmacokinetic Study of Testosterone Enanthate https://ClinicalTrials.gov/show/NCT01887418 Completed Antares Pharma Inc. 2014-01-31
NCT01880086 Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration https://ClinicalTrials.gov/show/NCT01880086 Completed Weill Medical College of Cornell University 2016-03-31
NCT01873989 Testosterone Replacement for Male Opioid Agonist Maintained Patients https://ClinicalTrials.gov/show/NCT01873989 Completed Yale University 2015-01-31
NCT01816295 A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy https://ClinicalTrials.gov/show/NCT01816295 Completed Eli Lilly and Company 2014-10-31
NCT01765179 Safety and Efficacy Trial of Testosterone Undecanoate https://ClinicalTrials.gov/show/NCT01765179 Completed Clarus Therapeutics, Inc. 2013-07-31
NCT01748370 Vitamin D Treatment and Hypogonadism in Men https://ClinicalTrials.gov/show/NCT01748370 Completed Medical University of Graz 2017-11-12
NCT01739595 Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism https://ClinicalTrials.gov/show/NCT01739595 Completed Repros Therapeutics Inc. 2013-09-30
NCT01739582 An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism https://ClinicalTrials.gov/show/NCT01739582 Completed Repros Therapeutics Inc. 2014-04-30
NCT01717768 Oral Testosterone for the Treatment of Hypogonadism https://ClinicalTrials.gov/show/NCT01717768 Completed TesoRx Pharma, LLC 2014-08-31
NCT01709331 A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937) https://ClinicalTrials.gov/show/NCT01709331 Completed Merck Sharp & Dohme Corp. 2015-04-08
NCT01703741 A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel https://ClinicalTrials.gov/show/NCT01703741 Completed Ferring Pharmaceuticals 2013-10-31
NCT01699178 Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men https://ClinicalTrials.gov/show/NCT01699178 Completed Clarus Therapeutics, Inc. 2014-04-30
NCT01665599 A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel https://ClinicalTrials.gov/show/NCT01665599 Completed Ferring Pharmaceuticals 2013-04-30
NCT01623570 Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP https://ClinicalTrials.gov/show/NCT01623570 Completed Centro Riproduzione e Andrologia 2012-05-31
NCT01619683 Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism https://ClinicalTrials.gov/show/NCT01619683 Completed Repros Therapeutics Inc. 2014-09-30
NCT01601327 Effects of Medications in Patients With Hypogonadism https://ClinicalTrials.gov/show/NCT01601327 Completed Gulhane School of Medicine 2012-03-31
NCT04320745 A Study to Evaluate Androderm’s Effect on Blood Pressure in Adult Hypogonodal Male Participants. https://ClinicalTrials.gov/show/NCT04320745 Recruiting Allergan 2020-08-27
NCT01534208 Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism https://ClinicalTrials.gov/show/NCT01534208 Completed Repros Therapeutics Inc. 2013-10-31
NCT01533129 The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism https://ClinicalTrials.gov/show/NCT01533129 Completed Gulhane School of Medicine 2011-04-30
NCT01532414 Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism https://ClinicalTrials.gov/show/NCT01532414 Completed Repros Therapeutics Inc. 2013-03-31
NCT01454011 The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups https://ClinicalTrials.gov/show/NCT01454011 Completed Gulhane School of Medicine 2011-02-28
NCT01438073 Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling https://ClinicalTrials.gov/show/NCT01438073 Recruiting Massachusetts General Hospital 2023-09-30
NCT01438034 Kisspeptin in the Evaluation of Delayed Puberty https://ClinicalTrials.gov/show/NCT01438034 Recruiting Massachusetts General Hospital 2023-11-30
NCT01446042 Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism https://ClinicalTrials.gov/show/NCT01446042 Completed Acerus Pharmaceuticals Corporation 2012-12-31
NCT01419236 A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels https://ClinicalTrials.gov/show/NCT01419236 Completed Eli Lilly and Company 2013-12-31
NCT01403532 Sequential Therapy for Hypogonadotropic Hypogonadism https://ClinicalTrials.gov/show/NCT01403532 Completed Shanghai Jiao Tong University School of Medicine 2012-12-31
NCT01403116 Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men https://ClinicalTrials.gov/show/NCT01403116 Completed Clarus Therapeutics, Inc. 2013-09-30
NCT01386606 The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone) https://ClinicalTrials.gov/show/NCT01386606 Completed Repros Therapeutics Inc. 2011-10-31
NCT01386567 A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203 https://ClinicalTrials.gov/show/NCT01386567 Completed Repros Therapeutics Inc. 2013-01-31
NCT01378299 CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy https://ClinicalTrials.gov/show/NCT01378299 Completed VA Office of Research and Development 2016-11-07
NCT01370369 Efficacy, Pharmacokinetics and Safety of Testosterone https://ClinicalTrials.gov/show/NCT01370369 Completed Ferring Pharmaceuticals 2011-07-31
NCT01323140 Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems https://ClinicalTrials.gov/show/NCT01323140 Completed Watson Pharmaceuticals 2011-07-31
NCT04274894 A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism https://ClinicalTrials.gov/show/NCT04274894 Recruiting AbbVie 2020-12-17
NCT04049331 Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone https://ClinicalTrials.gov/show/NCT04049331 Recruiting Seattle Institute for Biomedical and Clinical Research 2024-12-01
NCT03245827 Hypogonadotropic Hypogonadism in Obese Young Males https://ClinicalTrials.gov/show/NCT03245827 Recruiting St. Louis University 2021-12-31
NCT03933618 Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function https://ClinicalTrials.gov/show/NCT03933618 Completed Albany Medical College 2017-03-08
NCT03887936 Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism https://ClinicalTrials.gov/show/NCT03887936 Recruiting VA Office of Research and Development 2024-09-30
NCT03868059 Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men https://ClinicalTrials.gov/show/NCT03868059 Completed Lipocine Inc. 2019-02-19
NCT03792477 A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males https://ClinicalTrials.gov/show/NCT03792477 Completed Pfizer 2020-04-02
NCT03792321 Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2) https://ClinicalTrials.gov/show/NCT03792321 Completed University Medical Centre Ljubljana 2015-03-05
NCT03687606 Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH) https://ClinicalTrials.gov/show/NCT03687606 Recruiting Tongji Hospital 2024-10-01
NCT03619330 Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism. https://ClinicalTrials.gov/show/NCT03619330 Completed University Medical Centre Ljubljana 2015-08-31
NCT03541395 Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males https://ClinicalTrials.gov/show/NCT03541395 Completed Lund University 2015-06-30
NCT03518034 A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men https://ClinicalTrials.gov/show/NCT03518034 Recruiting AbbVie 2022-06-30
NCT04456296 A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism https://ClinicalTrials.gov/show/NCT04456296 Recruiting Endo Pharmaceuticals 2022-04-30
NCT03490513 Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism https://ClinicalTrials.gov/show/NCT03490513 Recruiting Baylor College of Medicine 2023-04-14
NCT03418896 Extragonadal Effects of hCG on Calcium Homeostasis https://ClinicalTrials.gov/show/NCT03418896 Active, not recruiting Rigshospitalet, Denmark 2020-10-31
NCT01252745 Efficacy of an Intranasal Testosterone Product https://ClinicalTrials.gov/show/NCT01252745 Completed Acerus Pharmaceuticals Corporation 2010-11-30
NCT01228071 Time to Eugonadal Range, Time to Steady State and Drying Time https://ClinicalTrials.gov/show/NCT01228071 Completed Endo Pharmaceuticals 2011-05-31
NCT01206270 Androgen for Leydig Cell Proliferation https://ClinicalTrials.gov/show/NCT01206270 Completed University of Roma La Sapienza 2017-06-30
NCT01191320 Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus https://ClinicalTrials.gov/show/NCT01191320 Completed Repros Therapeutics Inc. 2011-12-31
NCT01160341 Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism https://ClinicalTrials.gov/show/NCT01160341 Completed Gulhane School of Medicine 2010-01-31
NCT01133548 Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males https://ClinicalTrials.gov/show/NCT01133548 Completed AbbVie 2010-07-31
NCT01127659 Testosterone Replacement in Men With Diabetes and Obesity https://ClinicalTrials.gov/show/NCT01127659 Completed University at Buffalo 2015-03-31
NCT01123278 Testosterone Replacement in Metabolic Syndrome and Inflammation https://ClinicalTrials.gov/show/NCT01123278 Completed University of Roma La Sapienza 2014-10-31
NCT01107067 Testosterone Replacement Therapy Decreases Plasma Paraoxonase 1 Enzyme Activity In Male Patients With Hypogonadism https://ClinicalTrials.gov/show/NCT01107067 Completed Gulhane School of Medicine 2009-12-31
NCT01104246 Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men https://ClinicalTrials.gov/show/NCT01104246 Completed Watson Pharmaceuticals 2010-09-30
NCT01084265 A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism https://ClinicalTrials.gov/show/NCT01084265 Completed Merck KGaA, Darmstadt, Germany 2005-12-31
NCT01067365 Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism https://ClinicalTrials.gov/show/NCT01067365 Completed Repros Therapeutics Inc. 2007-05-31
NCT01061970 Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy https://ClinicalTrials.gov/show/NCT01061970 Completed QuatRx Pharmaceuticals Company NA
NCT00998933 Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure https://ClinicalTrials.gov/show/NCT00998933 Completed Solvay Pharmaceuticals 2009-10-31
NCT00975650 Efficacy and Tolerability of an Intra-Nasal Testosterone Product https://ClinicalTrials.gov/show/NCT00975650 Completed Acerus Pharmaceuticals Corporation 2010-05-31
NCT00962637 Study to Evaluate the Safety and Efficacy of Androxalâ„¢ Treatment in Men With Secondary Hypogonadism https://ClinicalTrials.gov/show/NCT00962637 Completed Repros Therapeutics Inc. 2007-05-31
NCT00957528 Cycled Testosterone Replacement Study https://ClinicalTrials.gov/show/NCT00957528 Completed The University of Texas Medical Branch, Galveston 2008-12-31
NCT00924612 Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation https://ClinicalTrials.gov/show/NCT00924612 Completed Clarus Therapeutics, Inc. 2009-09-30
NCT00914823 Administration of Kisspeptin to Subjects With Reproductive Disorders https://ClinicalTrials.gov/show/NCT00914823 Recruiting Massachusetts General Hospital 2023-12-31
NCT00911586 Pharmacokinetic Study to Determine Time to Steady-state https://ClinicalTrials.gov/show/NCT00911586 Completed Clarus Therapeutics, Inc. 2009-09-30
NCT00857961 A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations https://ClinicalTrials.gov/show/NCT00857961 Completed Eli Lilly and Company 2008-01-31
NCT00857454 A Trial to Evaluate the Ongoing Skin Safety of Testosterone MD-Lotion Formulations https://ClinicalTrials.gov/show/NCT00857454 Completed Eli Lilly and Company 2009-08-31
NCT00857168 To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion https://ClinicalTrials.gov/show/NCT00857168 Completed Acrux DDS Pty Ltd 2009-02-28
NCT00837616 Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism https://ClinicalTrials.gov/show/NCT00837616 Completed Nemours Children’s Clinic 2012-06-30
NCT03345797 Evaluation of Testosterone Nasal Gel in Hypogonadal Boys https://ClinicalTrials.gov/show/NCT03345797 Recruiting Acerus Pharmaceuticals Corporation 2020-11-30
NCT03973840 Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes https://ClinicalTrials.gov/show/NCT03973840 Completed Clarus Therapeutics, Inc. 2018-07-31
NCT01560546 Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM) https://ClinicalTrials.gov/show/NCT01560546 Completed Odense University Hospital 2013-05-31
NCT03242590 Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021). https://ClinicalTrials.gov/show/NCT03242590 Completed Lipocine Inc. 2017-03-31
NCT03019575 Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) https://ClinicalTrials.gov/show/NCT03019575 Completed Merck Sharp & Dohme Corp. 2020-05-05
NCT03198728 Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men https://ClinicalTrials.gov/show/NCT03198728 Completed Marius Pharmaceuticals 2020-05-01
NCT00752869 Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement https://ClinicalTrials.gov/show/NCT00752869 Completed The Miriam Hospital 2012-03-31
NCT00706719 To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone https://ClinicalTrials.gov/show/NCT00706719 Completed Repros Therapeutics Inc. 2009-07-31
NCT00702650 A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations https://ClinicalTrials.gov/show/NCT00702650 Completed Eli Lilly and Company 2009-07-31
NCT00697814 Clomiphene in Males With Prolactinomas and Persistent Hypogonadism https://ClinicalTrials.gov/show/NCT00697814 Completed Federal University of São Paulo 2005-06-30
NCT00695110 Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men https://ClinicalTrials.gov/show/NCT00695110 Completed Clarus Therapeutics, Inc. 2008-12-31
NCT00663793 ORAL T-6: Oral Androgens in Man-6 https://ClinicalTrials.gov/show/NCT00663793 Completed University of Washington 2009-05-31
NCT00647868 NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers https://ClinicalTrials.gov/show/NCT00647868 Completed Acerus Pharmaceuticals Corporation 2009-03-31
NCT00613782 Reandron in Diabetic Men Witn Low Testosterone Level https://ClinicalTrials.gov/show/NCT00613782 Completed Austin Health 2014-01-31
NCT00613288 Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism https://ClinicalTrials.gov/show/NCT00613288 Completed University of Aarhus 2009-09-30
NCT00597051 Study of 3 Doses of ARD-0403 in Testosterone Deficient Men https://ClinicalTrials.gov/show/NCT00597051 Completed Ardana Bioscience Ltd 2006-02-28
NCT00522431 A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone https://ClinicalTrials.gov/show/NCT00522431 Completed Endo Pharmaceuticals 2008-03-31
NCT00504712 Testosterone for Peripheral Vascular Disease https://ClinicalTrials.gov/show/NCT00504712 Completed Barnsley Hospital 2009-12-31
NCT00493961 Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism https://ClinicalTrials.gov/show/NCT00493961 Active, not recruiting Massachusetts General Hospital 2022-02-28
NCT00487734 Effect of Testosterone Replacement on Insulin Resistance https://ClinicalTrials.gov/show/NCT00487734 Completed McGuire Research Institute 2010-10-31
NCT00475501 5-Alpha Reductase and Anabolic Effects of Testosterone https://ClinicalTrials.gov/show/NCT00475501 Completed VA Office of Research and Development 2012-03-31
NCT00470990 Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men https://ClinicalTrials.gov/show/NCT00470990 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2008-06-30
NCT00467870 Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men https://ClinicalTrials.gov/show/NCT00467870 Completed Endo Pharmaceuticals 2009-07-31
NCT00456274 Baselines in Reproductive Disorders https://ClinicalTrials.gov/show/NCT00456274 Recruiting Massachusetts General Hospital 2020-09-30
NCT00452322 Safety of Testosterone Undecanoate i.m. in Hypogonadal Men https://ClinicalTrials.gov/show/NCT00452322 Completed University Hospital Muenster NA
NCT00448955 Open-Label Study of ARD-0403 in Testosterone Deficient Men https://ClinicalTrials.gov/show/NCT00448955 Completed Ardana Bioscience Ltd 2008-02-29
NCT00434824 Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203) https://ClinicalTrials.gov/show/NCT00434824 Completed Merck Sharp & Dohme Corp. 2004-07-31
NCT00433199 Testosterone Treatment for Hypogonadal Men https://ClinicalTrials.gov/show/NCT00433199 Completed Abbott 2007-10-31
NCT00431197 Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men https://ClinicalTrials.gov/show/NCT00431197 Completed Mayo Clinic 2007-12-31
NCT00421460 The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction https://ClinicalTrials.gov/show/NCT00421460 Completed Chulalongkorn University 2011-01-31
NCT00415571 Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors https://ClinicalTrials.gov/show/NCT00415571 Completed QuatRx Pharmaceuticals Company NA
NCT00400335 Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride https://ClinicalTrials.gov/show/NCT00400335 Completed GlaxoSmithKline NA
NCT00398580 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men https://ClinicalTrials.gov/show/NCT00398580 Completed GlaxoSmithKline 2007-10-31
NCT00392912 Effect of Testosterone Therapy in Men With Alzheimer’s Disease and Low Testosterone https://ClinicalTrials.gov/show/NCT00392912 Completed VA Medical Center, Houston 2009-11-30
NCT00392756 Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS) https://ClinicalTrials.gov/show/NCT00392756 Recruiting Massachusetts General Hospital 2022-02-28
NCT00392457 Investigating the Regulation of Reproductive Hormones in Adult Men https://ClinicalTrials.gov/show/NCT00392457 Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2007-02-28
NCT00383656 Pulsatile GnRH in Anovulatory Infertility https://ClinicalTrials.gov/show/NCT00383656 Recruiting Massachusetts General Hospital 2020-09-30
NCT00372008 Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males https://ClinicalTrials.gov/show/NCT00372008 Completed Acrux DDS Pty Ltd 2007-04-30
NCT00365794 Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men https://ClinicalTrials.gov/show/NCT00365794 Completed University of Southern California 2013-12-31
NCT00351819 Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception https://ClinicalTrials.gov/show/NCT00351819 Completed Boston University 2012-11-30
NCT00349362 Testosterone for Men With Insulin Treated Type 2 Diabetes https://ClinicalTrials.gov/show/NCT00349362 Completed Barnsley Hospital 2008-10-31
NCT00345969 Exercise and Testosterone Therapy in Elderly Men With Physical Frailty https://ClinicalTrials.gov/show/NCT00345969 Completed Washington University School of Medicine 2009-02-28
NCT00290134 A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism https://ClinicalTrials.gov/show/NCT00290134 Completed QuatRx Pharmaceuticals Company NA
NCT00287586 Testosterone Replacement in Older Men and Atherosclerosis Progression https://ClinicalTrials.gov/show/NCT00287586 Completed Brigham and Women’s Hospital 2012-02-07
NCT00266864 Testosterone Replacement Therapy in Chronic Spinal Cord Injury https://ClinicalTrials.gov/show/NCT00266864 Completed VA Office of Research and Development 2012-08-31
NCT00244023 Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone https://ClinicalTrials.gov/show/NCT00244023 Completed SELARL du Dr Jacques BUVAT 2007-07-31
NCT00223860 Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury. https://ClinicalTrials.gov/show/NCT00223860 Completed VA Office of Research and Development 2007-12-31
NCT00220298 Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism https://ClinicalTrials.gov/show/NCT00220298 Completed Bayer 2007-10-31
NCT00202462 The Effect of Testosterone on Mood and Quality of Life https://ClinicalTrials.gov/show/NCT00202462 Completed Seattle Institute for Biomedical and Clinical Research 2005-12-31
NCT00194675 TRADE-Testosterone Replacement and Dutasteride Effectiveness https://ClinicalTrials.gov/show/NCT00194675 Completed University of Washington 2010-04-30
NCT00193700 Pharmacokinetic Evaluation of Testosterone Gel (1%) https://ClinicalTrials.gov/show/NCT00193700 Completed Solvay Pharmaceuticals NA
NCT00193661 Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism https://ClinicalTrials.gov/show/NCT00193661 Completed Solvay Pharmaceuticals 2007-03-31
NCT00179517 Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo https://ClinicalTrials.gov/show/NCT00179517 Completed Beth Israel Deaconess Medical Center 2008-04-30
NCT00161486 The Effects of Testosterone on Prostate Tissue (ACYP-1) https://ClinicalTrials.gov/show/NCT00161486 Completed University of Washington 2004-11-30
NCT00161421 Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone https://ClinicalTrials.gov/show/NCT00161421 Completed University of Washington 2006-07-31
NCT00141492 Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT00141492 Completed Solvay Pharmaceuticals 2007-06-30
NCT00140998 Estrogen Treatment (Oral vs. Patches) in Turner Syndrome https://ClinicalTrials.gov/show/NCT00140998 Completed Nemours Children’s Clinic NA
NCT00138710 Short-term Effects of Aromatase Inhibition in Obese Men https://ClinicalTrials.gov/show/NCT00138710 Completed Rijnstate Hospital 2010-01-31
NCT00136695 Anastrozole Administration in Elderly Hypogonadal Men https://ClinicalTrials.gov/show/NCT00136695 Completed Massachusetts General Hospital 2008-10-31
NCT00119483 Older Men and Testosterone https://ClinicalTrials.gov/show/NCT00119483 Completed University Hospital of North Norway NA
NCT00104572 Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. https://ClinicalTrials.gov/show/NCT00104572 Completed National Institutes of Health Clinical Center (CC) 2013-12-31
NCT00080483 Testosterone and Growth Hormone for Bone Loss in Men https://ClinicalTrials.gov/show/NCT00080483 Completed University of Pennsylvania 2010-09-30
NCT00048841 Prevention of Osteoporosis in Men With Prostate Cancer https://ClinicalTrials.gov/show/NCT00048841 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA
NCT00004438 Leuprolide in Treating Adults With Hypogonadotropism https://ClinicalTrials.gov/show/NCT00004438 Completed FDA Office of Orphan Products Development NA
NCT00004426 Leuprolide in Determining the Cause of Gonadotropin Deficiency https://ClinicalTrials.gov/show/NCT00004426 Completed FDA Office of Orphan Products Development NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03256292 Long-term Lifestyle Change and Testosterone Replacement https://ClinicalTrials.gov/show/NCT03256292 Enrolling by invitation Baylor College of Medicine 2021-08-31
NCT03254641 Calciotropic Effects After hCG Stimulation Test https://ClinicalTrials.gov/show/NCT03254641 Active, not recruiting Rigshospitalet, Denmark 2020-03-31
NCT03063125 Hypogonadism in Bladder Cancer https://ClinicalTrials.gov/show/NCT03063125 Active, not recruiting University of Kansas Medical Center 2020-05-30
NCT02728440 Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism https://ClinicalTrials.gov/show/NCT02728440 Completed Gulhane School of Medicine 2012-12-31
NCT02665559 Study of the Prevalence and Associated Factors With Hypogonadism in HIV + Men https://ClinicalTrials.gov/show/NCT02665559 Completed Tourcoing Hospital 2016-06-30
NCT01500447 Inherited Reproductive Disorders https://ClinicalTrials.gov/show/NCT01500447 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02471157 Hormonal Predictors of Oncologic Surgery https://ClinicalTrials.gov/show/NCT02471157 Completed Weill Medical College of Cornell University 2016-10-31
NCT02434562 Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation https://ClinicalTrials.gov/show/NCT02434562 Completed Universitaire Ziekenhuizen Leuven 2016-09-30
NCT02248467 Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric Patients https://ClinicalTrials.gov/show/NCT02248467 Completed University of Florence 2017-12-31
NCT02240966 Symptoms and Clinical Signs of Hypogonadism in Testicular Cancer Survivors https://ClinicalTrials.gov/show/NCT02240966 Completed Rigshospitalet, Denmark 2016-07-31
NCT02062307 Bone Mineral Markers in Hypogonadism https://ClinicalTrials.gov/show/NCT02062307 Completed Gulhane School of Medicine 2013-07-31
NCT01511588 Hormonal Regulation of Puberty and Fertility https://ClinicalTrials.gov/show/NCT01511588 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01758094 Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism https://ClinicalTrials.gov/show/NCT01758094 Completed Gulhane School of Medicine 2012-08-31
NCT03747003 Gonadal Function in Young to Middle Aged HIV-infected Men https://ClinicalTrials.gov/show/NCT03747003 Active, not recruiting Azienda Ospedaliero-Universitaria di Modena 2017-12-31
NCT03484260 Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone https://ClinicalTrials.gov/show/NCT03484260 Completed Bayer 2018-05-15
NCT03437109 Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus https://ClinicalTrials.gov/show/NCT03437109 Completed Besins Healthcare 2019-02-01
NCT01172366 A Study to Evaluate the Potential for Interpersonal Transfer of Testosterone Following Single Dose Application https://ClinicalTrials.gov/show/NCT01172366 Completed Acrux DDS Pty Ltd 2010-09-30
NCT01148433 Quality of Life With TESTIM® https://ClinicalTrials.gov/show/NCT01148433 Completed Ferring Pharmaceuticals 2011-06-30
NCT01143818 ESPRIT Study in Hypogonadal Men https://ClinicalTrials.gov/show/NCT01143818 Completed Abbott 2010-08-31
NCT00858650 Registry of Hypogonadism in Men https://ClinicalTrials.gov/show/NCT00858650 Completed HealthCore-NERI 2013-09-30
NCT00847314 Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients https://ClinicalTrials.gov/show/NCT00847314 Completed Bayer 2008-10-31
NCT00838838 Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis https://ClinicalTrials.gov/show/NCT00838838 Completed Bayer 2009-05-31
NCT01601171 The Genetic Investigation of Reproductive Disorders (Including Kallmann Syndrome) https://ClinicalTrials.gov/show/NCT01601171 Recruiting Centre Hospitalier Universitaire Vaudois 2022-03-31
NCT01914172 Health Needs of Patients With Kallmann Syndrome https://ClinicalTrials.gov/show/NCT01914172 Completed Centre Hospitalier Universitaire Vaudois 2014-03-31
NCT01703676 Epigenetics and Metabolic Disorders in Men With the Klinefelter Syndrome https://ClinicalTrials.gov/show/NCT01703676 Completed University Hospital Muenster 2012-05-31
NCT00624624 Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic Hypogonadism https://ClinicalTrials.gov/show/NCT00624624 Completed Rijnstate Hospital 2011-03-31
NCT00494169 Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders https://ClinicalTrials.gov/show/NCT00494169 Recruiting Massachusetts General Hospital 2023-05-31
NCT00483418 Survey of Testosterone Levels in Male Cancer Patients https://ClinicalTrials.gov/show/NCT00483418 Completed Beth Israel Medical Center 2009-12-31
NCT00472940 Prevalence of Hypogonadism in Male Cancer Patients https://ClinicalTrials.gov/show/NCT00472940 Completed Baylor College of Medicine NA
NCT00425568 Transdermal Testosterone Gel/Effect on Erection Quality as Measured by DIR https://ClinicalTrials.gov/show/NCT00425568 Completed Lamm, Steven, M.D. NA
NCT00410306 Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice https://ClinicalTrials.gov/show/NCT00410306 Completed Bayer 2010-07-31
NCT00170339 Bone Density and Serum Testosterone in Male Methadone Maintained Patients https://ClinicalTrials.gov/show/NCT00170339 Completed Hennepin Healthcare Research Institute NA
NCT00001412 Effects on the Brain of Lupron Induced Hypogonadotropic Hypogonadism With and Without Testosterone Replacement https://ClinicalTrials.gov/show/NCT00001412 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001275 Ovarian Follicle Function in Patients With Primary Ovarian Failure https://ClinicalTrials.gov/show/NCT00001275 Completed National Institutes of Health Clinical Center (CC) NA
NCT00004335 Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle https://ClinicalTrials.gov/show/NCT00004335 Completed National Center for Research Resources (NCRR) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02042638 The Effects of Gonadotropin Replacement Therapy in Patients With Hypogonadism https://ClinicalTrials.gov/show/NCT02042638 Completed Gulhane School of Medicine 2013-08-31
NCT01793168 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford https://ClinicalTrials.gov/show/NCT01793168 Recruiting Sanford Health 2100-12-31